Advertisement Cresset Announces Appointment of Rob Scoffin as New CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Molecular Field Technology

More info about

Cresset Announces Appointment of Rob Scoffin as New CEO

“The appointment of Rob marks an exciting new chapter for Cresset,” said Andy Vinter, founder and chief scientific officer of Cresset. “Rob has a long track record of close collaboration with customers and successful commercial growth in the computational chemistry market place.” Outgoing CEO and chairman of the board, Bea Leigh commented, “We are excited to be working with Rob to further accelerate the company’s development and to achieve our aggressive corporate objectives.”

“This is a fantastic opportunity to join an established company with an excellent scientific reputation, and to help drive growth and enhanced commercial success in the future,” said Rob. “The Cresset team has worked hard to create a world-leading portfolio of products, and I am looking forward to helping bring those to new markets.”

Rob has a D.Phil. in chemistry from Oxford and has recently been instrumental in the development of Electronic Lab Notebook systems which he has deployed at several major pharmaceutical companies. Prior to CambridgeSoft, Rob was CEO (Software) for Amedis and senior product manager at Oxford Molecular.